HomeInsightsEPS

Aurobindo Pharma Ltd EPS

Aurobindo Pharma Ltd EPS

stocks purchased

₹ 0.9 Cr

Volume Transacted

(Jan 22, 2025)

stocks purchased

7.2 K

Stocks Traded

(Jan 22, 2025)

Last Updated on: Jan 22, 2025

Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

EPS

₹ 62.24

Last updated on: Jan 21, 2025

Key Highlights

  • The Earning per Share of Aurobindo Pharma Ltd is ₹ 62.24 as of 21 Jan 25 .
  • The earning per share of Aurobindo Pharma Ltd changed from ₹ 9.74 to ₹ 14 over 6 quarters. This represents a CAGR of 27.36% .

Historical Earning per Share of Aurobindo Pharma Ltd

No data available

* All values are in

Company Fundamentals for Aurobindo Pharma Ltd

Market Cap

69,533 Cr

EPS

62.2

P/E Ratio (TTM) *

19.1

P/B Ratio (TTM) *

2.3

Day’s High *

1194.25

Day’s Low

1171.55

DTE *

0.3

ROE *

11.6

52 Week High

1592.55

52 Week Low

959.05

ROCE *

13.7

Market Price of Aurobindo Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Aurobindo Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Jan 20251186.7
20 Jan 20251202.7
17 Jan 20251177.85
16 Jan 20251156.6
15 Jan 20251147.35
14 Jan 20251174.9
13 Jan 20251161.85
10 Jan 20251200.1
09 Jan 20251248.7
08 Jan 20251281.65

SWOT Analysis Of Aurobindo Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Aurobindo Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Aurobindo Pharma Ltd

Market Value

69,533

Asset Value

25,059

1.8 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Aurobindo Pharma Ltd6269,533
Sun Pharmaceuticals Industries Ltd464,22,715
Divis Laboratories Ltd691,54,460
Cipla Ltd571,15,271
Dr Reddys Laboratories Ltd631,07,511
Torrent Pharmaceuticals Ltd511,06,863

Historical Market Cap of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Aurobindo Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Aurobindo Pharma Ltd News Hub

News

Aurobindo Pharma tumbles after US FDA issues warning letter to Telangana unit

In May 2024, the United States Food and Drug Administration (US FDA) had conducted an insp...

Read more

2024-08-16 00:00:00

News

Eugia Pharma Specialities receives USFDA warning for Unit III

Aurobindo Pharma announced that the USFDA has issued a warning letter for Unit-III of Eugi...

Read more

2024-08-16 00:00:00

News

Aurobindo Pharma consolidated net profit rises 61.05% in the June 2024 quarter

Net profit of Aurobindo Pharma rose 61.05% to Rs 919.22 crore in the quarter ended June 20...

Read more

2024-08-12 00:00:00

News

Auro Pharma gets USFDA nod for atrophic vaginitis drug

The approved drug is bioequivalent and therapeutically equivalent to the reference listed ...

Read more

2024-08-07 00:00:00

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

FAQs for EPS of Aurobindo Pharma Ltd

What is the EPS of Aurobindo Pharma Ltd stock?

The Earnings Per Share (EPS) of Aurobindo Pharma Ltd is 62.24. An EPS is the amount of net income attributed to each share of a common stock.

How is Aurobindo Pharma Ltd EPS calculated?

The EPS of Aurobindo Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Aurobindo Pharma Ltd report its EPS?

Aurobindo Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Aurobindo Pharma Ltd EPS?

Factors that influence the EPS of Aurobindo Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Aurobindo Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Aurobindo Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions